- Home
- NVRO vs CINGW Comparison
NVRO vs CINGW Comparison
Compare NVRO & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVRO
- CINGW
- Stock Information
- Founded
- NVRO 2006
- CINGW N/A
- Country
- NVRO United States
- CINGW United States
- Employees
- NVRO N/A
- CINGW 13
- Industry
- NVRO Medical/Dental Instruments
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- NVRO Health Care
- CINGW Health Care
- Exchange
- NVRO Nasdaq
- CINGW Nasdaq
- Market Cap
- NVRO 134.5M
- CINGW N/A
- IPO Year
- NVRO 2014
- CINGW 2021
- Fundamental
- Price
- NVRO $3.69
- CINGW $0.06
- Analyst Decision
- NVRO Hold
- CINGW
- Analyst Count
- NVRO 14
- CINGW 0
- Target Price
- NVRO $7.97
- CINGW N/A
- AVG Volume (30 Days)
- NVRO 416.5K
- CINGW N/A
- Earning Date
- NVRO 02-19-2025
- CINGW N/A
- Dividend Yield
- NVRO N/A
- CINGW N/A
- EPS Growth
- NVRO N/A
- CINGW N/A
- EPS
- NVRO N/A
- CINGW N/A
- Revenue
- NVRO $419,146,000.00
- CINGW N/A
- Revenue This Year
- NVRO N/A
- CINGW N/A
- Revenue Next Year
- NVRO $0.65
- CINGW N/A
- P/E Ratio
- NVRO N/A
- CINGW N/A
- Revenue Growth
- NVRO N/A
- CINGW N/A
- 52 Week Low
- NVRO $3.52
- CINGW N/A
- 52 Week High
- NVRO $21.74
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- NVRO 43.89
- CINGW N/A
- Support Level
- NVRO $3.60
- CINGW N/A
- Resistance Level
- NVRO $3.90
- CINGW N/A
- Average True Range (ATR)
- NVRO 0.28
- CINGW 0.00
- MACD
- NVRO 0.01
- CINGW 0.00
- Stochastic Oscillator
- NVRO 39.56
- CINGW 0.00
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.